Investing.com - Nextgen Healthcare (NASDAQ: NXGN) reported fourth quarter EPS of $0.31, $0.02 better than the analyst estimate of $0.29. Revenue for the quarter came in at $178.6M versus the consensus estimate of $171.13M.
Guidance
Nextgen Healthcare sees FY 2024 EPS of $1.04-$1.11 versus the analyst consensus of $0.96.
Nextgen Healthcare sees FY 2024 revenue of $712.00M-$722.00M versus the analyst consensus of $645.80M.
Nextgen Healthcare's stock price closed at $16.89. It is down -10.92% in the last 3 months and down -15.89% in the last 12 months.
Nextgen Healthcare saw 3 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Nextgen Healthcare's stock price’s past reactions to earnings here.
According to InvestingPro, Nextgen Healthcare's Financial Health score is "good performance".
Check out Nextgen Healthcare's recent earnings performance, and Nextgen Healthcare's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar